Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL28523054 | 0.87 | TAAR1 (0.48) | TAAR1LMNAHTR1ADRD2HTR7 | |
| Cadaverine Tartrate SCHEMBL30733604 | 0.87 | TAAR1 (0.48) | TAAR1LMNAHTR1ADRD2HTR7 | |
| Tartaric Acid SCHEMBL30733603 | 0.87 | TAAR1 (0.48) | TAAR1LMNAHTR1ADRD2HTR7 | |
| Cadaverine Tartrate SCHEMBL29223353 | 0.87 | TAAR1 (0.48) | TAAR1LMNAHTR1ADRD2HTR7 | |
| SCHEMBL28518877 | 0.81 | TAAR1 (0.45) | TAAR1HTR1ADRD2HTR7KDM4E | |
| SCHEMBL28511085 | 0.81 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL30733601 | 0.81 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| SCHEMBL28511084 | 0.81 | TAAR1 (0.60) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL29140413 | 0.80 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 | |
| Hydrochloric Acid SCHEMBL30733605 | 0.80 | TAAR1 (0.59) | TAAR1HTR1ADRD2HTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118406063-A | Salt, crystal forms and preparation method thereof | 赛诺维信制药公司 | 2024-07-30 | — | — | CN | claimed |
| CN-118576586-A | Methods of treating neurological and psychiatric disorders | 住友制药美国公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118406063-A | Salt, crystal forms and preparation method thereof | 赛诺维信制药公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-112135827-B | Salt, crystal forms and preparation method thereof | 赛诺维信制药公司 | 2024-01-12 | — | — | CN | disclosed |